Yao JC, Hassan M, Phan A, et al. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008;26:3063–72.
Khashab MA, Yong E, Lennon AM, et al. EUS is still superior to multidetector computerized tomography for detection of pancreatic neuroendocrine tumors. Gastrointest Endosc. 2011;73:691–6.
Ito T, Igarashi H, Nakamura K, et al. Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis. J Gastroenterol. 2015;50:58–64.
Hijioka S, Hara K, Mizuno N, et al. Diagnostic performance and factors influencing the accuracy of EUS-FNA of pancreatic neuroendocrine neoplasms. J Gastroenterol. 2016;51:923–30.
Article CAS PubMed PubMed Central Google Scholar
Lee LC, Grant CS, Salomao DR, et al. Small, nonfunctioning, asymptomatic pancreatic neuroendocrine tumors (PNETs): role for nonoperative management. Surgery. 2012;152:965–74.
Hackert T, Hinz U, Fritz S, et al. Enucleation in pancreatic surgery: indications, technique, and outcome compared to standard pancreatic resections. Langenbecks Arch Surg. 2011;396:1197–203.
Watzka FM, Laumen C, Fottner C, et al. Resection strategies for neuroendocrine pancreatic neoplasms. Langenbecks Arch Surg. 2013;398:431–40.
Article CAS PubMed Google Scholar
Beger HG. Benign tumors of the pancreas-radical surgery versus parenchyma-sparing local resection-the challenge facing surgeons. J Gastrointest Surg. 2018;22:562–6.
Ito T, Masui T, Komoto I, et al. JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis. J Gastroenterol. 2021;56:1033–44.
Article CAS PubMed PubMed Central Google Scholar
Shah MH, Goldner WS, Benson AB, et al. Neuroendocrine and adrenal tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2021;19:839–68.
Article CAS PubMed Google Scholar
Howe JR, Merchant NB, Conrad C, et al. The North American neuroendocrine tumor society consensus paper on the surgical management of pancreatic neuroendocrine tumors. Pancreas. 2020;49:1–33.
Article PubMed PubMed Central Google Scholar
Pavel M, de Herder WW. ENETS consensus guidelines for the standard of care in neuroendocrine tumors. Neuroendocrinology. 2017;105:193–5.
Article CAS PubMed Google Scholar
Gaujoux S, Partelli S, Maire F, et al. Observational study of natural history of small sporadic nonfunctioning pancreatic neuroendocrine tumors. J Clin Endocrinol Metab. 2013;98:4784–9.
Article CAS PubMed Google Scholar
Rosenberg AM, Friedmann P, Del Rivero J, et al. Resection versus expectant management of small incidentally discovered nonfunctional pancreatic neuroendocrine tumors. Surgery. 2016;159:302–9.
Choi JH, Choi YH, Kang J, et al. Natural history of small pancreatic lesions suspected to be nonfunctioning pancreatic neuroendocrine tumors. Pancreas. 2018;47:1357–63.
Kurita Y, Hara K, Kuwahara T, et al. Comparison of prognosis between observation and surgical resection groups with small sporadic non-functional pancreatic neuroendocrine neoplasms without distant metastasis. J Gastroenterol. 2020;55:543–52.
Manfredi R, Bonatti M, Mantovani W, et al. Non-hyperfunctioning neuroendocrine tumours of the pancreas: MR imaging appearance and correlation with their biological behaviour. Eur Radiol. 2013;23:3029–39.
Humphrey PE, Alessandrino F, Bellizzi AM, et al. Non-hyperfunctioning pancreatic endocrine tumors: multimodality imaging features with histopathological correlation. Abdom Imaging. 2015;40:2398–410.
Kim JJ, Walia S, Lee SH, et al. Lower yield of endoscopic ultrasound-guided fine-needle aspiration in patients with pancreatic head mass with a biliary stent. Dig Dis Sci. 2015;60:543–9.
Article CAS PubMed Google Scholar
Paiella S, Landoni L, Rota R, et al. Endoscopic ultrasound-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors: a retrospective analysis of 110 cases. Endoscopy. 2020;52:988–94.
Yoshinaga S, Itoi T, Yamao K, et al. Safety and efficacy of endoscopic ultrasound-guided fine needle aspiration for pancreatic masses: a prospective multicenter study. Dig Endosc. 2020;32:114–26.
Liu K, Xie P, Peng W, et al. Assessment of dynamic contrast-enhanced magnetic resonance imaging in the differentiation of pancreatic ductal adenocarcinoma from other pancreatic solid lesions. J Comput Assist Tomogr. 2014;38:681–6.
Mukai S, Itoi T, Ashida R, et al. Multicenter, prospective, crossover trial comparing the door-knocking method with the conventional method for EUS-FNA of solid pancreatic masses (with videos). Gastrointest Endosc. 2016;83:1210–7.
Ramesh J, Kim H, Reddy K, et al. Performance characteristic of endoscopic ultrasound-guided fine needle aspiration is unaffected by pancreatic mass size. Endosc Int Open. 2016;4:E434–8.
Article PubMed PubMed Central Google Scholar
Takahashi K, Yasuda I, Hanaoka T, et al. Diagnostic fine-needle biopsy of small solid pancreatic lesions using a Franseen needle during endoscopic ultrasound examination. Diagnostics (Basel). 2020;11:27.
Kwon W, Jang JY, Song KB, et al. Risk factors for recurrence in pancreatic neuroendocrine tumor and size as a surrogate in determining the treatment strategy: A Korean nationwide study. Neuroendocrinology. 2021;111:794–804.
Article CAS PubMed Google Scholar
Khanna L, Prasad SR, Sunnapwar A, et al. Pancreatic neuroendocrine neoplasms: 2020 update on pathologic and imaging findings and classification. Radiographics. 2020;40:1240–62.
Bang JY, Krall K, Jhala N, et al. Comparing needles and methods of endoscopic ultrasound-guided fine needle biopsy to optimize specimen quality and diagnostic accuracy for patients with pancreatic masses in a randomized trial. Clin Gastroenterol Hepatol. 2021;19:825-35.e7.
Nagtegaal ID, Odze RD, Klimstra D, et al. The 2019 WHO classification of tumours of the digestive system. Histopathology. 2020;76:182–8.
Cotton PB, Eisen GM, Aabakken L, et al. A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc. 2010;71:446–54.
Haba S, Yamao K, Bhatia V, et al. Diagnostic ability and factors affecting accuracy of endoscopic ultrasound-guided fine needle aspiration for pancreatic solid lesions: Japanese large single center experience. J Gastroenterol. 2013;48:973–81.
Nakai Y, Hamada T, Hakuta R, et al. Endoscopic ultrasonography-guided tissue acquisition for small solid pancreatic lesions: does the size matter? DEN Open. 2022;2: e52.
Tanaka H, Matsusaki S. The utility of endoscopic-ultrasonography-guided tissue acquisition for solid pancreatic lesions. Diagnostics (Basel). 2022;12:753.
Article CAS PubMed PubMed Central Google Scholar
Park JK, Lee KH. Present and future of endoscopic ultrasound-guided tissue acquisition in solid pancreatic tumors. Clin Endosc. 2019;52:541–8.
Article PubMed PubMed Central Google Scholar
Gkolfakis P, Crinò SF, Tziatzios G, et al. Comparative diagnostic performance of end-cutting fine-needle biopsy needles for EUS tissue sampling of solid pancreatic masses: a network meta-analysis. Gastrointest Endosc. 2022;95:1067-77.e15.
Kanno A, Yasuda I, Irisawa A, et al. Adverse events of endoscopic ultrasound-guided fine-needle aspiration for histologic diagnosis in Japanese tertiary centers: multicenter retrospective study. Dig Endosc. 2021;33:1146–57.
Katanuma A, Maguchi H, Yane K, et al. Factors predictive of adverse events associated with endoscopic ultrasound-guided fine needle aspiration of pancreatic solid lesions. Dig Dis Sci. 2013;58:2093–9.
Article CAS PubMed PubMed Central Google Scholar
Kitano M, Yoshida M, Ashida R, et al. Needle tract seeding after endoscopic ultrasound-guided tissue acquisition of pancreatic tumors: a nationwide survey in Japan. Dig Endosc. 2022.
Nanno Y, Matsumoto I, Zen Y, et al. Pancreatic duct involvement in well-differentiated neuroendocrine tumors is an independent poor prognostic factor. Ann Surg Oncol. 2017;24:1127–33.
留言 (0)